Paper40211368
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.
Zhang M and 1 other. Exp Hematol Oncol, 2025. Cited by 209 papers, by iCite.
Cite this record
ConductScience Library. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Papers, record 40211368. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211368
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References204
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36746510 | Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors. | J Immunother Cancer | 2023 | https://conductscience.org/library/papers/36746510 | PubMed |
| 2 | 19931152 | Matrix crosslinking forces tumor progression by enhancing integrin signaling. | Cell | 2009 | https://conductscience.org/library/papers/19931152 | PubMed |
| 3 | 36684109 | Pin1/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36684109 | PubMed |
| 4 | 34297718 | Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness. | PLoS Comput Biol | 2021 | https://conductscience.org/library/papers/34297718 | PubMed |
| 5 | 34106045 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. | Elife | 2021 | https://conductscience.org/library/papers/34106045 | PubMed |
| 6 | 21744247 | Matrix metalloproteinases in tumorigenesis: an evolving paradigm. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21744247 | PubMed |
| 7 | 24851253 | [Paul Bornstein (1934–2013), a pioneer of matrix biology and pathology]. | Pathol Biol (Paris) | 2014 | https://conductscience.org/library/papers/24851253 | PubMed |
| 8 | 31319162 | Revisiting the hallmarks of cancer: The role of hyaluronan. | Semin Cancer Biol | 2020 | https://conductscience.org/library/papers/31319162 | PubMed |
| 9 | 35659296 | Characteristics of the cancer stem cell niche and therapeutic strategies. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35659296 | PubMed |
| 10 | 22053288 | Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. | Cancer Discov | 2011 | https://conductscience.org/library/papers/22053288 | PubMed |
| 11 | 23649148 | Positive and negative influence of the matrix architecture on antitumor immune surveillance. | Cell Mol Life Sci | 2013 | https://conductscience.org/library/papers/23649148 | PubMed |
| 12 | 25893917 | Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/25893917 | PubMed |
| 13 | 33513979 | Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33513979 | PubMed |
| 14 | 25376097 | Is there new hope for therapeutic matrix metalloproteinase inhibition? | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/25376097 | PubMed |
| 15 | 33287873 | Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/33287873 | PubMed |
| 16 | 33008805 | Soft Microenvironments Induce Chemoresistance by Increasing Autophagy Downstream of Integrin-Linked Kinase. | Cancer Res | 2020 | https://conductscience.org/library/papers/33008805 | PubMed |
| 17 | 21240262 | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. | Nat Med | 2011 | https://conductscience.org/library/papers/21240262 | PubMed |
| 18 | 31324706 | Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis. | Essays Biochem | 2019 | https://conductscience.org/library/papers/31324706 | PubMed |
| 19 | 32483419 | CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway. | Theranostics | 2020 | https://conductscience.org/library/papers/32483419 | PubMed |
| 20 | 26258633 | Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/26258633 | PubMed |
Cited by178
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983536 | Metabolic-extracellular matrix crosstalk in hepatocellular carcinoma: mechanisms and targeted intervention. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42983536 | PubMed |
| 42978946 | Mechanochemical coupling in lung cancer: how tissue tension drives genomic instability and malignant progression. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42978946 | PubMed |
| 42958443 | HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translation. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42958443 | PubMed |
| 42955533 | QSOX1 as a mediator of tumor-fibroblast crosstalk and a modulator of pulmonary tumor burden in lung adenocarcinoma. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42955533 | PubMed |
| 42941901 | Metabolic Dysfunction and T-Cell Exhaustion in Colorectal Cancer: Mechanisms, Microenvironment Remodeling, and Therapeutic Opportunities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941901 | PubMed |
| 42910293 | ECM stiffness inhibits ferroptosis to promote HCC progression via the FOXA1-CDON-HMGB1/p53 pathway. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42910293 | PubMed |
| 42903636 | Impact of aging on the tumor microenvironment in oral cancer: Mechanisms and therapeutic perspectives. | J Taibah Univ Med Sci | 2026 | https://conductscience.org/library/papers/42903636 | PubMed |
| 42898419 | Hydrogel-based smart bioinks for 3D bioprinting: design strategies and applications in brain tissue engineering and tumor microenvironment modelling. | Bioimpacts | 2026 | https://conductscience.org/library/papers/42898419 | PubMed |
| 42888420 | Niches in cancer: from primary tumors to metastatic disease. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42888420 | PubMed |
| 42859163 | Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42859163 | PubMed |
| 42832574 | Exploring the key genes of colorectal "adenoma-cancer" based on graph transformer. | PLoS One | 2026 | https://conductscience.org/library/papers/42832574 | PubMed |
| 42828102 | Engineered probiotics couple photothermal cuproptosis with biomechanical disruption and immune activation. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42828102 | PubMed |
| 42798839 | Identification and assessment of FN1, MET, KRT19 and CLDN1 as key dysregulated genes in papillary thyroid cancer through transcriptomic profiling and expression analysis. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42798839 | PubMed |
| 42793270 | Current Perspectives on 2D and 3D Cell Culture Models in Cancer Research: Molecular Determinants of Tumor Biology and Therapeutic Response. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42793270 | PubMed |
| 42792643 | An L1CAM-Positive Fibroblast-Associated Stromal State Is Associated with Reduced T/NK Cytotoxicity Features in Colorectal Cancer. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792643 | PubMed |
| 42787254 | Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42787254 | PubMed |
| 42782738 | Biomarker-Driven Strategies for Stromal Reprogramming in Pancreatic Ductal Adenocarcinoma. | Cells | 2026 | https://conductscience.org/library/papers/42782738 | PubMed |
| 42766730 | Fibroblast-associated TPM2 links cell-matrix remodeling to EMT-Notch signaling and gemcitabine resistance in intrahepatic cholangiocarcinoma. | Cancer Biol Ther | 2026 | https://conductscience.org/library/papers/42766730 | PubMed |
| 42749970 | LOXL4: a key regulatory factor at the intersection of fibrosis and tumor progression. | Hum Cell | 2026 | https://conductscience.org/library/papers/42749970 | PubMed |
| 42738717 | Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects. | Molecules | 2026 | https://conductscience.org/library/papers/42738717 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40211368
GET https://conductscience.org/api/papers/v1/40211368/references?page=2